PTGX
Protagonist Therapeutics Inc
$103.78
+0.11% (+$0.11)
Volume
601,602
52W High
$107.84
52W Low
$39.60
Market Cap
$5.46B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$0.65
Whisper EPS
-$0.65
0.4% below consensus
Last Quarter
-$0.69
Current Streak
1 Miss
Avg Surprise (4Q)
-50.59%
Next Earnings Report
Reports in 28 days
Price Chart
EPS History: Consensus vs Actual
Last 9 quartersPrice Movement Around Earnings
Q4 2025
Mar 18, 2026
1-Day:
+4.73%
5-Day:
+1.49%
Q4 2025
Feb 27, 2026
5-Day:
+2.99%
Q4 2025
Feb 23, 2026
1-Day:
+0.92%
Q4 2025
Feb 20, 2026
5-Day:
+5.24%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $7.4M | -95.6% | 94.9% | -677.1% | -$44.4M |
| Q3'25 | $4.7M | +0.8% | 100.0% | -985.2% | -$39.3M |
| Q2'25 | $5.5M | +33.1% | 100.0% | -758.0% | -$34.8M |
| Q1'25 | $28.3M | -88.9% | 100.0% | -68.2% | -$11.7M |
| Q4'24 | $170.6M | +184.4% | 100.0% | 74.3% | $131.7M |
| Q3'24 | $4.7M | +444.2% | 100.0% | -886.7% | -$33.2M |
| Q2'24 | $4.2M | -83.8% | 100.0% | -931.0% | -$30.6M |
| Q1'24 | $255.0M | +2,858.7% | 100.0% | 80.9% | $207.3M |
Company Information
Symbol
PTGX
Company
Protagonist Therapeutics Inc
Market Cap
$5.46B
Next Earnings
May 5, 2026